The PreOncology Program™
Personalized cancer prevention built on whole genome sequencing, precision risk assessment, and continuous clinical guidance.
How the Program Works
Primary care physicians introduce the PreOncology Program to their patients. Interested patients register in the PreOncology Platform™ and begin with the Stage Alpha Assessment, the entry point into the program.
Using whole genome sequencing, advanced cancer risk modeling, family history, lifestyle factors, and clinical data, PreOncology™ creates a personalized cancer prevention and early detection strategy designed around the members unique biology.
The Stage Alpha Assessment
Step 1
Blood Draw
A single blood draw that produces a oncology specific genomic analysis that is more comprehensive than any hereditary cancer risk genetic testing currently available. This test is performed once and continuously reinterpreted as science advances.
Step 2
Precision Risk Assessment
A structured clinical intake capturing personal and family history, lifestyle factors, and other clinically relevant inputs used to build each member’s risk profile.
Step 3
Initial Consultation with the Prevention Care Team
A dedicated review session in which the Prevention Care Team presents the member’s personalized risk profile and individualized prevention plan. The team includes a board-certified medical oncologist or nurse practitioner specializing in prevention and early detection, and an oncology-specialized genetic counselor.
Following the Initial Consultation, a full report is presented to the member and their primary care physician through the PreOncology Platform.
Screening Technologies
